Nisa Investment Advisors’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-4,350
Closed -$120 2361
2021
Q2
$120 Hold
4,350
﹤0.01% 1603
2021
Q1
$72 Hold
4,350
﹤0.01% 1891
2020
Q4
$80K Buy
+4,350
New +$77.9K ﹤0.01% 1831

Nisa Investment Advisors's TBIO Position: Q3 2021 in Review

Nisa Investment Advisors sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 4,350 shares — an estimated $120 sold.

Nisa Investment Advisors first reported a position in TBIO in Q4 2020 and held it in 3 quarters. The position peaked at $80K in Q4 2020. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • Nisa Investment Advisors reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Nisa Investment Advisors sold 4,350 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $120.
  • Nisa Investment Advisors first reported a position in Translate Bio, Inc. Common Stock in Q4 2020 and held it in 3 quarters.
  • Nisa Investment Advisors's Translate Bio, Inc. Common Stock position peaked at $80K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Nisa Investment Advisors's 13F filing for Q3 2021, filed 18 Oct 2021.